Investor Relations

mail icon

Sign Up For Email Alerts

Receive updates straight into your inbox

Sign up today

Company Overview

Inhibikase Therapeutics, Inc. is a pharmaceutical company focused on the development of protein kinase inhibitors for treatment of neurological infections and neurodegenerative diseases. The Company’s pipeline includes multiple product candidates developed from its proprietary RAMP drug innovation and prodrug technology engines, using the same clinically validated kinase target. The Company is headquartered in Atlanta with additional offices in Boston, Massachusetts.

Investor Contact Information

Company

Inhibikase Therapeutics, Inc.
3350 Riverwood Parkway
Suite 1900
Atlanta, GA 30339
T: 678-392-3419
info@inhibikase.com

Investor Relations

SternIR
Lisa Sher
T: 212-698-8700
lisa.sher@sternir.com

Transfer Agent

American Stock Transfer & Trust Company, LLC
T: 800-937-5449
help@astfinancial.com
astfinancial.com